ENDRA Life Sciences Inc.
USD5.04
-0.56 (-10.00%)
CEO
Alexander Y. Tokman
IPO Date
2017-06-30
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Country
US
Open
$5.62
Prev. Close
$5.60
Day Low
$4.95
Day High
$5.62
52W Low
$2.96
52W High
$11.96
Market Cap
$0.00B
Volume
0.03M
| 13,461 |
| $0.00 |
| 23 Jan 2026 | DIGIANDOMENICO ANTHONY | director | A-Award | Acquired | 60,324 | $0.00 |
| 23 Jan 2026 | Harsh Michael | director | A-Award | Acquired | 60,324 | $0.00 |
| 23 Jan 2026 | Jacroux Richard | Chief Financial Officer | A-Award | Acquired | 20,000 | $0.00 |
| 23 Jan 2026 | Basenese Lou | director | A-Award | Acquired | 60,324 | $0.00 |
| 23 Jan 2026 | Tokman Alexander Y | director, officer: Chief Executive Officer | A-Award | Acquired | 75,000 | $0.00 |
| 15 Oct 2025 | DIGIANDOMENICO ANTHONY | director | A-Award | Acquired | 70,822 | $7.06 |
| 15 Oct 2025 | DIGIANDOMENICO ANTHONY | director | A-Award | Acquired | 141,644 | $6.81 |
| 1 Jul 2025 | Basenese Lou | director | A-Award | Acquired | 5,384 | $0.00 |